INCITE
Incite GmbH has been developing and selling the industry-independent information and knowledge management software since 2003. The company, based in Sins (AG), is managed by the brothers Marc and Ivan Huber. In May 2016, she won the Innovation Award IT for her innovative knowledge platform at the CeBIT in Hanover for particularly innovative IT solutions with great benefits for SMEs.
INCITE
Industry:
Management Information Systems Service Industry Software
Founded:
2003-01-01
Address:
Sins, Aargau, Switzerland
Country:
Switzerland
Website Url:
http://www.incite.ch
Total Employee:
1+
Status:
Active
Contact:
+41 (0) 41 534 25 62
Email Addresses:
[email protected]
Technology used in webpage:
GlobalSign Thing Schema AlphaSSL
Similar Organizations
Likya Teknoloji
Likya Teknoloji offers end-to-end workload automation and data management software solutions.
SWS
SWS is an IT company that proides information management software services.
Official Site Inspections
http://www.incite.ch
- Host name: 104.247.82.50
- IP address: 104.247.82.50
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Incite"
About Incyte Switzerland | Biopharmaceutical Science
Incyte Biosciences International Sàrl. Rue Docteur-Yersin 12. 1110 Morges. Switzerland. Phone Number: +41 (0)21 581 50 00. For further information, contact our local team via [email protected]. Take a Tour of Our OfficeSee details»
Incyte - Wikipedia
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North Ameri…See details»
Culture & Careers - Incyte
At Incyte, we are convinced that our employees are most successful and able to realize innovative ideas if we let them be passionate, courageous and have fun. We encourage them to actively …See details»
Headquarters - Pharmaceutical Research
Incyte Biosciences International Sàrl. Rue Docteur-Yersin 12. 1110 Morges, Switzerland +41 (0) 21 581 50 00. View Map. AUSTRIA. DC Tower 1, Donau-City-Straße 7. 1220 Vienna Austria +43 1 35 808-03. Visit: Incyte Austria. …See details»
Our Leadership - Incyte
Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and allergy. He additionally held leadership roles …See details»
Incyte Biosciences International Sàrl – Swiss Biotech
Incyte is a company founded on the premise that investment in good science and the rigorous pursuit of R&D excellence can translate into new medicines that can positively affect patients' lives. ... Type of organization. Public company. Year …See details»
Incyte - Biopharmaceutical Company | Solutions for …
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.. Skip to main content Top navigation. …See details»
2023 GLOBAL RESPONSIBILITY REPORT - Incyte
INTRODUCTION PATIENTS AND INNOVATION COMMUNITY TEAM ENVIRONMENT GOVERNANCE AND RISK MANAGEMENT APPENDIX INCYTE 2023 GLOBAL …See details»
Global Biopharmaceutical Company | Incyte
Incyte is a Biopharmaceutical Company on a Mission to Solve On. ... Incyte has grown into a global organization with a robust portfolio of treatments across Oncology and Inflammation & …See details»
Incyte Biosciences International Sàrl at the Swiss Biotech Day
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development & …See details»
Incyte Switzerland Team | Incyte
Overall, Incyte is a company that values innovation, diversity, and employee well-being, making it potentially an excellent choice for those looking for a career in the pharmaceutical industry. …See details»
Global Biopharmaceutical Company | Incyte.com
Incyte is a Biopharmaceutical Company on a Mission to Solve On. 2500. Employees with operations in North America, Europe and Asia. 1000. ... Incyte has grown into a global …See details»
Incyte: A Global Biopharmaceutical Company on a Mission to …
Oct 19, 2023 A: Since starting with a small team of scientists, chemists, and biologists in Wilmington, Delaware in 2002, Incyte has grown into a global organization with a robust …See details»
Global Responsibility | Incyte.com
At Incyte, we believe that every employee plays a role in making a difference in the lives of the patients we serve. Our strength lies in the collective expertise, experience, passion and …See details»
Collaboration | Partners in Science | Incyte
We are pushing the bounds of what is possible in developing treatments for serious diseases with unmet needs, but we cannot do this alone. Forging strategic partnerships with companies, …See details»
Incyte inaugurates new European headquarters in Morges, …
Jul 7, 2020 U.S. biopharma Incyte has inaugurated its new European headquarters in Morges on July 6th. In parallel, the company is investing 100 million Swiss francs in a production facility in …See details»
Serving Patients Through Innovation | Incyte Stories
At Incyte, our passion for serving patients is what drives everything we do, and we are proud to be a global organization with in-house capabilities ranging from early discovery to manufacturing …See details»
Drug Development & Scientific Innovation in Oncology ... - Incyte
Focusing in areas where we can have a significant impact, regardless of the disease or size of the patient population, has resulted in a strong heritage of Incyte-discovered, first-in-class …See details»
Our Global Responsibility: By the Numbers | Incyte Stories
Over the past year, we have made significant progress toward advancing our Global Responsibility initiatives. We are confident the coming year will mark another remarkable …See details»